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Transcription in eukaryotic cells is performed by three RNA polymerases. RNA
polymerase I synthesises most rRNAs, whilst RNA polymerase II transcribes all mRNAs
and many non-coding RNAs. The largest of the three polymerases is RNA polymerase
III (Pol III) which transcribes a variety of short non-coding RNAs including tRNAs and
the 5S rRNA, in addition to other small RNAs such as snRNAs, snoRNAs, SINEs, 7SL
RNA, Y RNA, and U6 spilceosomal RNA. Pol III-mediated transcription is highly dynamic
and regulated in response to changes in cell growth, cell proliferation and stress. Pol
III-generated transcripts are involved in a wide variety of cellular processes, including
translation, genome and transcriptome regulation and RNA processing, with Pol III
dys-regulation implicated in diseases including leukodystrophy, Alzheimer’s, Fragile
X-syndrome and various cancers. More recently, Pol III was identified as an evolutionarily
conserved determinant of organismal lifespan acting downstream of mTORC1. Pol III
inhibition extends lifespan in yeast, worms and flies, and in worms and flies acts from the
intestine and intestinal stem cells respectively to achieve this. Intriguingly, Pol III activation
achieved through impairment of its master repressor, Maf1, has also been shown to
promote longevity in model organisms, including mice. In this review we introduce the
Pol III transcription apparatus and review the current understanding of RNA Pol III’s role
in ageing and lifespan in different model organisms. We then discuss the potential of Pol
III as a therapeutic target to improve age-related health in humans.
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INTRODUCTION
The transcription of the eukaryotic nuclear genome is performed by three, evolutionarily
conserved, multi-subunit RNA polymerases (Pols) that each transcribe a distinct set of genes.
A large proportion of the nuclear genome is transcribed by Pol II to generate both coding and
non-coding RNAs. In contrast, Pol I only transcribes a single gene, albeit present in multiple copies
within the genome, to produce the precursor to most rRNAs. While Pol I and III transcribe fewer
genes, they generate some of the most abundant cellular RNAs accounting for much of the cellular
transcriptional activity (White, 2008; Vannini and Cramer, 2012; Arimbasseri and Maraia, 2016).
With 17 subunits, Pol III is the largest of the three RNA polymerases (Vannini and Cramer,
2012). It transcribes several abundant, non-coding RNAs (up to a few hundred bases in length),
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some of which are involved in translation, such as the 5S rRNA
and tRNAs, some are involved in RNA processing, such as
a number of sn or snoRNAs, whereas others play regulatory
roles, such as 7SK RNA. Indeed, the list of Pol III-transcribed
genes has been expanding in recent times (Acker et al., 2013;
Turowski and Tollervey, 2016). Pol III function has also extended
beyond the canonical role in transcription of the nuclear genome
to now include responses to DNA viruses and homologous
recombination-mediated repair of DNA double-strand breaks
(Chiu et al., 2009; Liu et al., 2021). Pol III mediated transcription
is involved in a wide range of biological processes including cell
and organismal growth (Grewal et al., 2005, 2007; Halaschek-
Wiener et al., 2005; Chiu et al., 2009; Marshall et al., 2012;
Rideout et al., 2012), cell cycle (White et al., 1995), stemness and
differentiation (Wong et al., 2011; Alla and Cairns, 2014; Van
Bortle et al., 2017; Chen et al., 2018), development (Schmitt et al.,
2014), regeneration (Yeganeh et al., 2019), and cellular responses
to stress (Upadhya et al., 2002; Gouge et al., 2015). As a result,
Pol III subunits have been implicated in a wide variety of disease
states, reviewed by (Yeganeh and Hernandez, 2020).
POL III TRANSCRIPTIONAL MACHINERY
Recruitment of Pol III to its target genes is facilitated by
a number of dedicated, basal transcription factors (TFs),
where the exact combination of TFs involved is dictated by
the particular promoter present (reviewed in Schramm and
Hernandez (2002). Three types of promoter (Type I-III) recruit
Pol III, with all three requiring the binding of TFIIIB, a 3-
subunit TF containing the TATA box-binding protein (TBP).
Type I and Type II promoters are gene-internal, while type
III reside in the 5′ flanking region. Type II is present in
tRNA genes and additionally requires TFIIIC, a 6-subunit TF
that binds intragenic promoter elements. Type I promoter
is responsible for 5S rRNA gene transcription and employs
a further factor, TFIIIA, to direct TFIIIC binding. Type III
are distinct from Type I and II promoters as they do not
require TFIIIC for Pol III mediated transcription but employ
SNAPc, a TF also associated with Pol II transcription (Schramm
and Hernandez, 2002). This general set of promoter types
and TFs is essentially conserved across wide evolutionary
distances but with some phyla-specific differences (Schramm
and Hernandez, 2002; Teichmann et al., 2010). Additional TFs
regulating Pol III activity include Myc, a transcriptional activator
that can act on all three Pols (Gomez-Roman et al., 2003;
Campbell and White, 2014), as well as the protein Maf1, a
highly conserved repressor of Pol III activity (Upadhya et al.,
2002; Vorländer et al., 2020). Due to the critical functions of
RNA Pol III in growth and differentiation, it is perhaps not
altogether surprising that the signalling pathways influencing
these cellular processes can also interact and regulate Pol III
activity (Willis and Moir, 2018). Probably the most studied of
these is the highly conserved mTOR pathway (Wei et al., 2009;
Liu and Sabatini, 2020), which we will discuss in the following
section.
AGEING AND THE mTOR PATHWAY
The increased proportion of older people within our societies
has stimulated the study of the biology of ageing with the
hope that thorough understanding the mechanisms of ageing
we will come closer to identifying targets for intervention to
help prevent or ameliorate diseases of ageing (Partridge et al.,
2018). Indeed, several decades of research have shown that ageing
itself is highly plastic and can be modulated through genetic,
dietary and pharmacological means. For example, reduction
in the activity of the Target of Rapamycin kinase Complex 1
(TORC1) can promote longevity and healthspan in a number
of animal species (Erdogan et al., 2016; Liu and Sabatini, 2020).
The central component of the complex is mTOR, a 289 kDa
Ser/Thr kinase belonging to the PI3K-related protein kinase
(PIKK) family (Liu and Sabatini, 2020). TORC1 is activated in
the presence of nutrients and growth factors, essentially acting to
promote anabolic pathways while supressing catabolism. Given
that protein synthesis is one of the most highly energy-intensive
anabolic processes required for growth (Buttgereit and Brand,
1995), TORC1 tightly regulates the provision of protein synthetic
machinery, including regulation of Pol III activity. Indeed,
TORC1 has also been shown to localise to the promoters of a
number of rRNA and tRNA genes and control their transcription
(Li et al., 2006). It is this link between TORC1 and Pol III
that initially prompted us to investigate the role of Pol III in
organismal ageing.
RNA POLYMERASE III ACTS TO
PROMOTE ORGANISMAL AGEING
It is possible to reduce the activity of RNA Polymerase III in
model organisms by downregulating individual subunits of this
complex, through either a partial or restricted loss of function,
thereby avoiding organismal lethality that follows complete
loss. We found that in the nematode worm Caenorhabditis
elegans, RNAi targetted to the gene rpc-1, which encodes
the largest of the 17 Pol III subunits (orthologue of yeast
RPC160), significantly extended organismal lifespan (Filer
et al., 2017). This was also true in the fruit fly Drosophila
melanogaster, where RNAi of dC160 (the fly orthologue of
RPC160) extended lifespan, as did a heterozygous mutant of
another Pol III subunit dC53 (Filer et al., 2017). Indeed,
inducible loss of RPC160 in yeast also extended chronological
lifespan, thus demonstrating extensive evolutionary conservation
(Filer et al., 2017).
Since the longevity of an organism can be determined by a
specific organ, we tested whether this was also the case for Pol
III (Filer et al., 2017). As the intestine has previously been shown
to be important for modulating longevity in both worms and flies,
we focussed our attention on this tissue (Libina et al., 2003; Piper
et al., 2008). We showed that inhibiting Pol III activity in the
adult worm or fly gut using tissue-specific RNAi was sufficient to
extend lifespan; and more specifically in flies, longevity was also
achieved by Pol III inhibition exclusively within intestinal stem
cells (ISCs) (Filer et al., 2017). In contrast, downregulation of Pol
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III in the neurons and fat body of flies had little or no effect on
lifespan (Filer et al., 2017).
With advancing age, the function of many organ systems
and tissues deteriorates, contributing to physiological decline,
multimorbidity and ultimately death (Rera et al., 2012; Ezcurra
et al., 2018; Funk et al., 2020). For example, in worms and
flies the intestinal luminal wall begins to break down and
becomes more porous with advancing age, with similar changes
in intestinal permeability and barrier function reported in
mammals, including humans (Funk et al., 2020). We found
that the long life caused by Pol III knockdown was associated
with amelioration of age-related gut pathology and its ensuing
functional decline (Filer et al., 2017). Critically this suggests
that Pol III reduction is both a target for longevity and for
age-related health, and together with the intestinal longevity
data intestinal longevity points to tissue-specific functions of the
Pol III complex.
RNA POLYMERASE III AS A
DOWNSTREAM EFFECTOR OF TORC1
Importantly, we have also identified Pol III as a downstream
effector of TORC1 (Filer et al., 2017). Rapamycin is a macrolide
compound which inhibits activity of the TOR kinase and
rapamycin treatment extends lifespan in a range of organisms
(Bjedov et al., 2010; Arriola Apelo and Lamming, 2016), with
rapamycin treatment in flies decreasing pre-tRNAs in both whole
flies and within the intestine (Filer et al., 2017). Indeed, we
found that whilst both rapamycin and intestine- or ISC-specific
Pol III knockdown extended lifespan to a similar extent, these
treatments were not additive (Filer et al., 2017). These findings
led us to conclude that limiting Pol III activity in the fly adult gut
achieves the full longevity benefit of systemic TORC1 inhibition
and that Pol III is a key output of this highly conserved nutrient
signalling pathway that determines lifespan (Filer et al., 2017).
Our work shows that the growth-promoting, anabolic
functions mediated by Pol III activation are at least one
mechanism downstream of TORC1 that results in TORC1’s
activity curtailing adult health and survival (Filer et al., 2017;
Figure 1). Other known effectors of TORC1 include the
translational regulators S6 Kinase and 4E-BP1, in addition to
the autophagy regulators ATG1 and ULK1 (Liu and Sabatini,
2020). Inhibition of TORC1 with rapamycin also increases levels
of Histone H3 and H4 to induce autophagy (Lu et al., 2021).
Studies in multiple model systems demonstrate that these TORC1
outputs can all affect lifespan (Hansen et al., 2007; Pan et al.,
2007; Selman et al., 2009; Zid et al., 2009; Carvalho et al., 2017;
Fernández et al., 2018; Stead et al., 2019; Lu et al., 2021). TORC1
is part of a complex signalling network, the interactions of which
rarely work in isolation; the interaction between Pol III and each
of TORC1’s outputs remains to be defined (Figure 1).
MYC AND LONGEVITY
All three polymerases are regulated by the transcription factor
Myc, which has also been implicated both in the TORC1
pathway and in ageing (Gomez-Roman et al., 2003; Campbell
and White, 2014; Hofmann et al., 2015; Zhao et al., 2019).
Activation of TORC1 by amino acids requires the high affinity
glutamine transporter SLC1A5, which itself is transcribed by
Myc (Zhao et al., 2019). Reduced expression of Myc in Myc
heterozygous loss of function mice also leads to reduced TORC1
signalling, increases mouse lifespan, and improves a number
of age-related health conditions including osteoporosis, cardiac
fibrosis, immunosenescence and several parameters associated
with activity and lipid metabolism (Hofmann et al., 2015). This
link between Myc and longevity is conserved in the fly (Greer
et al., 2013). Thus, reduced activity of Myc is suggested as an
anti-ageing therapy target. Given that Myc is able to activate Pol
III transcription, it will be worth considering the interactions
between Myc, Pol III and ageing in the future.
MAF1 AND LONGEVITY
Previous research has shown that mTORC1 directly
phosphorylates Maf1, a key regulator of Poll III function
(Michels et al., 2010). Unphosphorylated Maf1 binds to the
polymerase and a subunit of TFIIIB preventing recruitment
of Pol III to promoters (Willis and Moir, 2018). Upon
phosphorylation by mTORC1, Maf1 is translocated from
the nucleus to the cytoplasm thus relieving Pol III from Maf1
repression (Oficjalska-Pham et al., 2006). For this review we are
primarily focussed on the role of Maf1 in regulating Pol III target
genes, although it should be noted that Maf1 may also regulate
Pol I and Pol II transcription in multiple species (Johnson et al.,
2007; Khanna et al., 2014; Palian et al., 2014; Zhang et al., 2018).
A number of studies by the Willis group have investigated
the role of Maf1 in metabolism and longevity in mice (Bonhoure
et al., 2015, 2020; Willis et al., 2018). They found that global Maf1
KO mice are resistant to both obesity and fatty liver disease when
fed a high fat diet (Bonhoure et al., 2015). Interestingly, female
Maf1 KO mice maintained on a chow diet had a significantly
extended lifespan relative to WT mice (Bonhoure et al., 2015).
While some of the beneficial metabolic effects observed upon loss
of Maf1 appear linked to energetically costly, futile RNA cycling
due to Pol III activation (Willis et al., 2018), it is still possible that
they may also be mediated in part by Pol II (see above).
In parallel, several groups have examined effects of Maf1 on
lifespan in invertebrates and yeast, with the findings appearing
somewhat inconsistent. The deletion of Maf1 in the budding yeast
S. cerevisiae shortened lifespan under high calorie (2% glucose)
and caloric restriction (CR) feeding and decreased resistance
to both heat and hydrogen peroxide (Cai and Wei, 2015,
2016). Similarly, loss of Maf1 in S. pombe resulted in shortened
chronological lifespan under low glucose conditions (Shetty et al.,
2020). In contrast, the loss of the Maf1 orthologue MAFR-1 in
C. elegans through RNAi knockdown extended lifespan under
normal and CR feeding, and increased stress resistance (Cai and
Wei, 2016). More recently, the Curran lab employed a CRISPR-
based approach to generate a mafr-1 null mutant and reported no
difference in the lifespan relative to WT worms (Hammerquist
and Curran, 2020), despite showing some phenotypic overlap
(e.g., increased expression of Pol III transcripts and elevated
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FIGURE 1 | Conserved relationships between TORC1, RNA Polymerase III and lifespan. The growth-promoting, anabolic functions mediated by Pol III activation
represent at least one mechanism downstream of TORC1 that shortens adult health and survival (Filer et al., 2017). The “Odd Pols” Pol I and Pol III have also been
implicated in disease states (Sharifi and Bierhoff, 2018; Zhang et al., 2018). TORC1 also controls the translational regulators S6 Kinase and 4E-BP1 as well as the
autophagy regulators ATG1 and ULK1 (Liu and Sabatini, 2020), and the H3 H4 Axis (Lu et al., 2021). NB Histones H3/H4 regulate expression of an autophagy cargo
adaptor Bchs (WDFY3 in mammals). Pol III is also regulated by MYC (as are Pol I and Pol II) which has also been implicated in the TORC1 pathway and in ageing
(Gomez-Roman et al., 2003; Campbell and White, 2014; Hofmann et al., 2015; Zhao et al., 2019). This figure focuses on work in the worm, fly and mouse. Studies
in these three model systems demonstrate that all of these TORC1 outputs can affect lifespan, as summarised here. As the structure and biochemical function of Pol
III is well studied, it is possible to design inhibitors that may provide therapeutic effects (Abascal-Palacios et al., 2018; Girbig et al., 2021).
intracellular lipids) with the mafr-1 RNAi knockdown worms
studied by Cai and colleagues (Cai and Wei, 2015, 2016). In
Drosophila, dMaf1 inhibition during development in either the
whole organism or the fat body increased larval growth rates
and body size, and enhanced protein synthesis rates through
increased insulin signalling (Rideout et al., 2012), while over-
expression in the adult gut moderately promoted longevity (Filer
et al., 2017). Taken together, these complex observations made
whilst studying Maf1 demonstrate a role for Maf1 in health
and longevity which could be mediated by the role of Maf1
in controlling Pol III. In particular, they raise an intriguing
possibility that both inhibition and activation of Pol III can
promote health and longevity, dependent on context such as diet,
tissue or organ where the intervention is implemented or even
the species being examined. However, an alternative explanation
is that the longevity of Maf1 loss of function is mediated by its
action on Pol I or Pol II.
MECHANISMS OF LONGEVITY
INCURRED BY POL III INHIBITION
As with all interventions that affect longevity it is critically
important to understand their mechanisms of action and whether
these mechanisms are conserved. We will now discuss several
putative mechanisms that may underlie the longevity phenotypes
associated with inhibition of Pol III, although it is important to
note that these putative mechanisms are not mutually exclusive.
Reduced protein translation is a well-established longevity
mechanism that may well underlie the longevity of Pol III
inhibition. Pol III is responsible for driving the transcription of
multiple small RNAs many of which play critical (but distinct)
roles in driving protein translation (Ikegami and Lieb, 2013;
Gruber, 2014; Filer et al., 2017; Pradhan et al., 2017; Sin et al.,
2017). Indeed, work on Pol III inhibition and lifespan focuses
specifically on its knockdown in adulthood, as blocking its
ability to promote translation during development is lethal.
For example, RNAi of rpc-1 in worms from embryonic stages
causes embryonic lethality, while loss-of-function mutation in
dC53 is homozygous lethal (Filer et al., 2017). Similarly, mice
homozygous for certain Pol III mutations are embryonic lethal
at day E3.5 or are postnatally stunted dying between P16 and
P25 (Choquet et al., 2019; Wang et al., 2020). Together, these
developmental defects demonstrate the importance of Pol III’s
provision of components of translation machinery for basic
physiological processes and strongly suggest that a careful balance
of translational capacity is required for optimal function, health
and longevity. Related to this, non-coding RNAs such as tRNAs
and rRNAs can also be the source of tRNA and rRNA fragments
(tRFs and rRFs). These RNA fragments play a role in translation
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and are implicated in several age-related diseases (Guzzi and
Bellodi, 2020) and the ageing process. It is possible that RNA Pol
III could influence their biogenesis either directly or indirectly.
Whether it is a reduction in global translation or a reduction
in translation of specific RNA species/families that contribute to
longevity is yet to be determined. The balance between protein
synthesis rates and quality control mechanisms to maintain
proteostasis is also critical during ageing (Riera et al., 2016; Sands
et al., 2017; Francisco et al., 2020). Given that the longevity
phenotype of Pol III gut-specific inhibition in Drosophila is
associated with enhanced resistance to proteotoxic challenge
(Filer et al., 2017), we suggest that investigating these processes
more fully in the context of Pol III across different organisms is
both timely and relevant.
Genomic instability and the accretion of genetic damage to
both genomic and mitochondrial DNA has been proposed as
one of the central hallmarks of ageing (López-Otín et al., 2013).
Protection against this damage in multicellular organisms is
complex and takes many forms, evidence of which can be found
in systems where Pol III activity is altered. In S. Pombe, when
Pol III is activated by the loss of maf1, increased DNA damage
of various tRNA genes was observed, but only significantly so
under CR conditions but not high-calorie conditions (Shetty
et al., 2020). Similarly, the Pol III-Maf1 axis has been shown
to play a role in protecting tRNA genes from DNA damage in
fission yeast, and can also respond to the DNA damage response
(Hammerquist et al., 2021; Noguchi et al., 2021). Pol III has
also been shown to produce transitory R-loops in double strand
breaks required for homologous recombination repair (Liu et al.,
2021). This method of double strand break repair is known to
be important for telomeres, thus Pol III may play a role in
telomere biology (Marnef and Legube, 2021; Tan et al., 2021).
Hence, it appears possible that reducing Pol III activity could
potentially impact ageing though reduced levels of DNA damage
(Callegari, 2016).
Finally, Pol III may also play an important, yet somewhat
under-appreciated role, in cellular metabolic processes. For
example, in yeast reduced Pol III activity is associated with de
novo amino acid synthesis, a decreased abundance of glycolytic
enzymes and reduced glycolytic flux. In contrast, in the same
study enhanced glycolytic flux was observed in Maf1-deficient
yeast cells (Cieśla et al., 2007; Szatkowska et al., 2019), with
evidence of greater hepatic glycolytic flux in fed Maf1 KO
mice (Willis et al., 2018). Thus, taken together there are several
candidate mechanisms via which Pol III inhibition may act
to increase lifespan and healthspan. Most are well established
longevity processes; deciphering exactly how they act or combine
to orchestrate the effects of Pol III will be intriguing.
SUMMARY
The evolutionary conservation of Pol III affirms its potential
as an exciting, novel therapeutic target for ageing and age-
related health. This conservation across organisms that span wide
evolutionary distances lends itself to an integrated-organismal
approach to its study. The underlying mechanisms may be
complex due to cross-talk between systems controlling gene
expression (Policarpi et al., 2017; Gerber et al., 2020). However,
the structure and biochemical function of Pol III is well studied,
providing a basis for design of polymerase inhibitors (Abascal-
Palacios et al., 2018; Girbig et al., 2021). Through a better
understanding of Pol III regulation, its transcriptional outputs,
the relevance of its tissue specificity and how mechanistically it
acts to modulate physiological function and health across the life-
course in distinct model systems (e.g., worms, flies, mice), we
believe it will be possible to exploit the specific advantages of each
system in order to maximise knowledge output on this important
lifespan determinant.
AUTHOR CONTRIBUTIONS
YK, YM, and GB contributed to the writing of the manuscript. JT,
NA, and CS supervised and edited the manuscript. All the authors
contributed to the article and approved the submitted version.
ACKNOWLEDGMENTS
We wish to acknowledge the support of the Biotechnology and
Biological Sciences Research Council (BBSRC) through grants
BB/R014507/1 and BB/S 14357/1 to NA, BB/S014330/1 to CS, and
BB/S014365/1 to JT.
REFERENCES
Abascal-Palacios, G., Ramsay, E. P., Beuron, F., Morris, E., and Vannini, A. (2018).
Structural basis of RNA polymerase III transcription initiation. Nature 553,
301–306. doi: 10.1038/nature25441
Acker, J., Conesa, C., and Lefebvre, O. (2013). Yeast RNA polymerase III
transcription factors and effectors. Biochim. Biophys. Acta Gene Regul. Mech.
1829, 283–295. doi: 10.1016/j.bbagrm.2012.10.002
Alla, R. K., and Cairns, B. R. (2014). RNA polymerase III transcriptomes in human
embryonic stem cells and induced pluripotent stem cells, and relationships with
pluripotency transcription factors. PLoS One 9:e85648. doi: 10.1371/journal.
pone.0085648
Arimbasseri, A. G., and Maraia, R. J. (2016). RNA Polymerase III Advances:
structural and tRNA Functional Views. Trends Biochem. Sci. 41, 546–559. doi:
10.1016/j.tibs.2016.03.003
Arriola Apelo, S. I., and Lamming, D. W. (2016). Rapamycin: an InhibiTOR of
aging emerges from the soil of Easter island. J. Gerontol. A Biol. Sci. Med. Sci.
71, 841–849. doi: 10.1093/gerona/glw090
Bjedov, I., Toivonen, J. M., Kerr, F., Slack, C., Jacobson, J., Foley, A., et al. (2010).
Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila
melanogaster. Cell Metab. 11, 35–46. doi: 10.1016/j.cmet.2009.11.010
Bonhoure, N., Byrnes, A., Moir, R. D., Hodroj, W., Preitner, F., Praz, V., et al.
(2015). Loss of the RNA polymerase III repressor MAF1 confers obesity
resistance. Genes Dev. 29, 934–947. doi: 10.1101/gad.258350.115
Bonhoure, N., Praz, V., Moir, R. D., Willemin, G., Mange, F., Moret, C., et al. (2020).
MAF1 is a chronic repressor of RNA polymerase III transcription in the mouse.
Sci. Rep. 10:11956. doi: 10.1038/s41598-020-68665-0
Buttgereit, F., and Brand, M. D. (1995). A hierarchy of ATP-consuming
processes in mammalian cells. Biochem. J. 312, 163–167. doi: 10.1042/bj31
20163
Frontiers in Genetics | www.frontiersin.org 5 July 2021 | Volume 12 | Article 705122
fgene-12-705122 June 30, 2021 Time: 16:36 # 6
Kulaberoglu et al. RNA Polymerase III, Ageing and Longevity
Cai, Y., and Wei, Y. H. (2015). Distinct regulation of Maf1 for lifespan extension
by Protein kinase A and Sch9. Aging 7, 133–143. doi: 10.18632/aging.100727
Cai, Y., and Wei, Y. H. (2016). Stress resistance and lifespan are increased in C.
elegans but decreased in S. cerevisiae by mafr-1/maf1 deletion. Oncotarget 7,
10812–10826. doi: 10.18632/oncotarget.7769
Callegari, A. J. (2016). Does transcription-associated DNA damage limit lifespan?
DNA Repair 41, 1–7. doi: 10.1016/j.dnarep.2016.03.001
Campbell, K. J., and White, R. J. (2014). MYC regulation of cell growth through
control of transcription by RNA polymerases I and III. Cold Spring Harb.
Perspect. Med. 4:a018408. doi: 10.1101/cshperspect.a018408
Carvalho, G. B., Drago, I., Hoxha, S., Yamada, R., Mahneva, O., Bruce, K. D., et al.
(2017). The 4E-BP growth pathway regulates the effect of ambient temperature
on Drosophila metabolism and lifespan. Proc. Natl. Acad. Sci. U. S. A. 114,
9737–9742. doi: 10.1073/pnas.1618994114
Chen, C. Y., Lanz, R. B., Walkey, C. J., Chang, W. H., Lu, W., and Johnson, D. L.
(2018). Maf1 and Repression of RNA Polymerase III-Mediated Transcription
Drive Adipocyte Differentiation. Cell Rep. 24, 1852–1864. doi: 10.1016/j.celrep.
2018.07.046
Chiu, Y.-H., MacMillan, J. B., and Chen, Z. J. (2009). RNA Polymerase III Detects
Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway. Cell
138, 576–591. doi: 10.1016/s9999-9994(09)20393-x
Choquet, K., Pinard, M., Yang, S., Moir, R. D., Poitras, C., Dicaire, M. J., et al.
(2019). The leukodystrophy mutation Polr3b R103H causes homozygote mouse
embryonic lethality and impairs RNA polymerase III biogenesis. Mol. Brain
12:59. doi: 10.1186/s13041-019-0479-7
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